The relationship between intracellular free iron and cell injury in cultured neurons, astrocytes, and oligodendrocytes

Journal of Neuroscience

Volumn 22, Issue 14, 2002, Pages 5848-5855

  Kress, Geraldine J ^a   Dineley, Kirk E ^a   Reynolds, Ian J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Astrocyte; Fluorescent dye; fura 2; Intracellular iron; Neuron; Oligodendrocyte

Indexed keywords

DEFEROXAMINE; FLUORESCENT DYE; FURA 2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN MITOCHONDRION; CELL COMPARTMENTALIZATION; CELL DAMAGE; CELL FATE; CELL TYPE; CELL VIABILITY; IRON METABOLISM; NERVE CELL CULTURE; NONHUMAN; OLIGODENDROGLIA; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT;

EID: 0037101622     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-14-05848.2002     Document Type: Article

References (56)

1. Aisen P (1994) The transferrin receptor and the release of iron from transferrin. Adv Exp Med Biol 356:31-40.
2. Aizenman E, Stout AK, Hartnett KA, Dineley KE, McLaughlin BA, Reynolds IJ (2000) Induction of neuronal apoptosis by thiol oxidation: Putative role of intracellular zinc release. J Neurochem 75:1878-1888.
3. Aschner M (1996) The functional significance of brain metallothioneins. FASEB J 10:1129-1136.
4. Baranano DE, Wolosker H, Bae BI, Barrow RK, Snyder SH, Ferris CD (2000) A mammalian iron ATPase induced by iron. J Biol Chem 275:15166-15173.
5. Beghetto C, Renken C, Eriksson O, Jori G, Bernardi P, Ricchelli F (2000) Implications of the generation of reactive oxygen species by photoactivated calcein for mitochondrial studies. Eur J Biochem 267:5585-5592.
6. Bralet J, Schreiber L, Bouvier C (1992) Effect of acidosis and anoxia on iron delocalization from brain homogenates. Biochem Pharmacol 43:979-983.
7. Breuer W, Epsztejn S, Cabantchik ZI (1995a) Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron(II). J Biol Chem 270:24209-24215.
8. Breuer W, Epsztejn S, Millgram P, Cabantchik IZ (1995b) Transport of iron and other transition metals into cells as revealed by a fluorescent probe. Am J Physiol 268:C1354-C1361.
9. Brocard JB, Tassetto M, Reynolds IJ (2001) Quantitative evaluation of mitochondrial calcium content following glutamate receptor stimulation in rat cortical neurones. J Physiol (Lond) 531:793-805.
10. Cabantchik ZI, Glickstein H, Milgram P, Breuer W (1996) A fluorescence assay for assessing chelation of intracellular iron in a membrane model system and in mammalian cells. Anal Biochem 233:221-227.
11. Castellani RJ, Siedlak SL, Perry G, Smith MA (2000) Sequestration of iron by Lewy bodies in Parkinson's disease. Acta Neuropathol 100:111-114.
12. Cheng C, Reynolds IJ (1998) Calcium-sensitive fluorescent dyes can report increases in intracellular free zinc concentration in cultured forebrain neurons. J Neurochem 71:2401-2410.
13. Connor JR (1997) Metals and Oxidative Damage in Neurological Disorders. New York: Plenum.
14. Connor JR, Menzies SL, St Martin SM, Mufson EJ (1992) A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res 31:75-83.
15. Crowe A, Morgan EH (1994) Effects of chelators on iron uptake and release by the brain in the rat. Neurochem Res 19:71-76.
16. Deibel MA, Ehmann WD, Markesbery WR (1996) Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: Possible relation to oxidative stress. J Neurol Sci 143:137-142.
17. Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem 52:1830-1836.
18. i. Neurobiol Dis 7:310-320.
19. Dorrepaal CA, Berger HM, Benders MJ, Zoeren-Grobben D, Van de Bor M, Van Bel F (1996) Nonprotein-bound iron in postasphyxial reperfusion injury of the newborn. Pediatrics 98:883-889.
20. Gardner PR (1997) Superoxide-driven aconitase Fe-S center cycling. Biosci Rep 17:33-42.
21. Gerlach M, Ben-Shachar D, Riederer P, Youdim MBH (1994) Altered brain metabolism of iron as a cause of neurodegenerative diseases. J Neurochem 63:793-807.
22. Gocht A, Keith AB, Candy JM, Morris CM (1993) Iron uptake in the brain of the myelin-deficient rat. Neurosci Lett 154:187-190.
23. Golub MS, Han B, Keen CL (1996) Aluminum alters iron and manganese uptake and regulation of surface transferrin receptors in primary rat oligodendrocyte cultures. Brain Res 719:72-77.
24. Good PF, Perl DP, Bierer LM, Schmeidler J (1992) Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study. Ann Neurol 31:286-292.
25. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
26. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger MA (1997) Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388:482-488.
27. Hulet SW, Heyliger SO, Powers S, Connor JR (2000) Oligodendrocyte progenitor cells internalize ferritin via clathrin-dependent receptor mediated endocytosis. J Neurosci Res 61:52-60.
28. Jellinger KA (1999) The role of iron in neurodegeneration: Prospects for pharmacotherapy of Parkinson's disease. Drugs Aging 14:115-140.
29. Kienzl E, Jellinger K, Stachelberger H, Linert W (1999) Iron as catalyst for oxidative stress in the pathogenesis of Parkinson's disease? Life Sci 65:1973-1976.
30. 2+ induced neurotoxicity. Soc Neurosci Abstr 26:2071.
31. Lauffer RB (1992) Iron and Human Disease. Boca Raton, FL: CRC.
32. LeVine SM (1997) Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res 760:298-303.
33. Lipscomb DC, Gorman LG, Traystman RJ, Hurn PD (1998) Low molecular weight iron in cerebral ischemic acidosis in vivo. Stroke 29:487-492.
34. Malecki EA, Devenyi AG, Beard JL, Connor JR (1999) Existing and emerging mechanisms for transport of iron and manganese to the brain. J Neurosci Res 56:113-122.
35. McCarthy KD, de Vellis J (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
36. Petrat F, Rauen U, De Groot H (1999) Determination of the chelatable iron pool of isolated rat hepatocytes by digital fluorescence microscopy using the fluorescent probe, phen green SK. Hepatology 29:1171-1179.
37. Picard V, Govoni G, Jabado N, Gros P (2000) Nramp 2 (DCT1/DMT1) expressed at the plasma membrane transports iron and other divalent cations into a calcein-accessible cytoplasmic pool. J Biol Chem 275:35738-35745.
38. Qian ZM, Tang PL (1995) Mechanisms of iron uptake by mammalian cells. Biochim Biophys Acta 1269:205-214.
39. Qian ZM, Wang Q (1998) Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders. Brain Res Brain Res Rev 27:257-267.
40. Rauen U, Petrat F, Li T, De Groot H (2000) Hypothermia injury/coldinduced apoptosis-evidence of an increase in chelatable iron causing oxidative injury in spite of low O2-/H2O2 formation. FASEB J 14:1953-1964.
41. Reif DW (1992) Ferritin as a source of iron for oxidative damage. Free Radic Biol Med 12:417-427.
42. Schapira AH (1999) Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia. Biochim Biophys Acta 1410:159-170.
43. Smith MA, Nunomura A, Zhu X, Takeda A, Perry G (2000) Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. Antioxid Redox Signal 2:413-420.
44. Sofic E, Riederer P, Heinsen H, Beckmann H, Reynolds GP, Hebenstreit G, Youdim MB (1988) Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm 74:199-205.
45. Staubli A, Boelsterli UA (1998) The labile iron pool in hepatocytes: Prooxidant-induced increase in free iron precedes oxidative cell injury. Am J Physiol 274:G1031-G1037.
46. Swaiman KF, Machen VL (1984) Iron uptake by mammalian cortical neurons. Ann Neurol 16:66-70.
47. Swaiman KF, Machen VL (1985) Iron uptake by glial cells. Neurochem Res 10:1635-1644.
48. Thompson KJ, Shoham S, Connor JR (2001) Iron and neurodegenerative disorders. Brain Res Bull 55:155-164.
49. Tsien RY (1999) Monitoring cell calcium. In: Calcium as a Cellular Regulator (Carafoli E, Klee CB, eds), pp 28-54. New York: Oxford UP.
50. Votyakova TV, Reynolds IJ (2001) Δψm-dependent and independent production of reactive oxygen species by brain mitochondria. J Neurochem 79:266-277.
51. Waldvogel D, van Gelderen P, Hallett M (1999) Increased iron in the dentate nucleus of patients with Friedrich's ataxia. Ann Neurol 46:123-125.
52. Wardman P, Candeias LP (1996) Fenton chemistry: An introduction. Radiat Res 145:523-531.
53. Wessling-Resnick M (1999) Biochemistry of iron uptake. Crit Rev Biochem Mol Biol 34:285-314.
54. Winterbourn CC (1995) Toxicity of iron and hydrogen peroxide: The Fenton reaction. Toxicol Lett 82-83:969-974.
55. Youdim MB, Ben Shachar D, Yehuda S, Riederer P (1990) The role of iron in the basal ganglion. Adv Neurol 53:155-162.
56. Zanninelli G, Glickstein H, Breuer W, Milgram P, Brissot P, Hider RC, Konijn AM, Libman J, Shanzer A, Cabantchik ZI (1997) Chelation and mobilization of cellular iron by different classes of chelators. Mol Pharmacol 51:842-852.